Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Leukemia, Myeloid, Acute 11Myelodysplastic Syndromes 9Lymphoma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia 6Hematologic Neoplasms 6Neuroblastoma 4Neoplasms 4Lymphoma, Non-Hodgkin 4Leukemia, Biphenotypic, Acute 4Leukemia, B-Cell 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Melanoma 3Leukemia, Lymphoid 3Hodgkin Disease 3Hematologic Diseases 3Sarcoma 2Rhabdoid Tumor 2Recurrence 2Preleukemia 2Precancerous Conditions 2Osteosarcoma 2Neoplasms, Germ Cell and Embryonal 2Neoplasms by Histologic Type 2Multiple Myeloma 2Lymphoproliferative Disorders 2Lymphatic Diseases 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myeloid 2

Interventions

Cyclophosphamide 7venetoclax 5fludarabine phosphate 5tagraxofusp 3fludarabine 3Whole-Body Irradiation 3Thiotepa 3Mycophenolic Acid 3Methotrexate 3merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Tacrolimus 2Specimen Handling 2Rituximab 2Dexamethasone 2Cytarabine 2Cyclosporins 2Cyclosporine 2Calcium Dobesilate 2prednylidene 1exifone 1deltacortene 1azathiopurine 1X-Rays 1Vincristine 1Sirolimus 1Ranitidine 1Prednisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Blastic Plasmacytoid Dendritic Cell Neoplasm × Mesna × 1 year × Clear all
NCT04318678 2026-05-19

CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

St. Jude Children's Research Hospital

Phase 1 Recruiting
108 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡